Difficulty: Medium
Average Score: 79%
Practice
Which patient would be most likely to be cured with chemotherapy as a treatment measure?
Correct answer
B
Rationale
In the context of pharmacology and immune system disorders, understanding the appropriate use of chemotherapy is crucial. In this quiz question, the correct answer is B) New neuroblastoma.
Neuroblastoma is a type of cancer that originates in nerve tissue and is commonly found in young children. Chemotherapy is often an effective treatment for neuroblastoma due to its ability to target rapidly dividing cells, which is a hallmark of cancer cells. In the case of a new neuroblastoma, where the cancer is at an early stage and has not spread extensively, chemotherapy stands a good chance of curing the patient by eradicating the cancerous cells.
Now, let's analyze why the other options are incorrect:
A) Small cell lung cancer: While chemotherapy is a common treatment for small cell lung cancer, the word "cured" is rarely associated with this treatment due to the aggressive nature of the disease and the likelihood of recurrence.
C) Small tumor of the bone: Chemotherapy is not typically the first-line treatment for small tumors of the bone. Surgical removal or localized treatments like radiation therapy are usually preferred.
D) Large hepatocellular carcinoma: Chemotherapy may be used to slow the progression of hepatocellular carcinoma or to shrink the tumor before surgery, but curing this advanced stage cancer with chemotherapy alone is unlikely.
Understanding the appropriate use of chemotherapy in different types and stages of cancer is essential for healthcare professionals involved in the treatment of patients with immune system disorders. This knowledge helps in making informed decisions regarding the most effective treatment strategies based on individual patient conditions, ultimately aiming for the best possible outcomes.
Neuroblastoma is a type of cancer that originates in nerve tissue and is commonly found in young children. Chemotherapy is often an effective treatment for neuroblastoma due to its ability to target rapidly dividing cells, which is a hallmark of cancer cells. In the case of a new neuroblastoma, where the cancer is at an early stage and has not spread extensively, chemotherapy stands a good chance of curing the patient by eradicating the cancerous cells.
Now, let's analyze why the other options are incorrect:
A) Small cell lung cancer: While chemotherapy is a common treatment for small cell lung cancer, the word "cured" is rarely associated with this treatment due to the aggressive nature of the disease and the likelihood of recurrence.
C) Small tumor of the bone: Chemotherapy is not typically the first-line treatment for small tumors of the bone. Surgical removal or localized treatments like radiation therapy are usually preferred.
D) Large hepatocellular carcinoma: Chemotherapy may be used to slow the progression of hepatocellular carcinoma or to shrink the tumor before surgery, but curing this advanced stage cancer with chemotherapy alone is unlikely.
Understanding the appropriate use of chemotherapy in different types and stages of cancer is essential for healthcare professionals involved in the treatment of patients with immune system disorders. This knowledge helps in making informed decisions regarding the most effective treatment strategies based on individual patient conditions, ultimately aiming for the best possible outcomes.